XML 43 R33.htm IDEA: XBRL DOCUMENT v3.21.1
14. STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Feb. 28, 2021
Share-based Payment Arrangement [Abstract]  
Compensation costs related to the Company's stock-based compensation

    The following table summarizes the stock-based compensation expense for the three and nine months ended February 28, 2021 and February 29, 2020 (in thousands):

 

   Three Months Ended  Nine Months Ended
   February 28,  February 29,  February 28,  February 29,
   2021  2020  2021  2020
Stock-based compensation in the form of employee stock options, RSUs and ESPP purchase rights, included in:            
Cost of sales  $14   $19   $45   $58 
Selling, general and administrative   194    137    593    401 
Research and development   63    51    160    152 
Total stock-based compensation  $271   $207   $798   $611 

 

Fair value assumptions for option valuation model

    Fair Value. The fair values of the Company’s stock options granted to employees for the three and nine months ended February 28, 2021 and February 29, 2020, were estimated using the following weighted average assumptions in the Black-Scholes option valuation model:

 

   Three Months Ended  Nine Months Ended
   February 29,  February 28,  February 29,
   2020  2021  2020
          
Expected term (in years)   5    6    5 
Volatility   0.72    0.72    0.71 
Risk-free interest rate   1.57%   0.39%   1.85%
Weighted average grant date fair value  $1.37   $1.09   $0.98 

 

Fair value assumption of the ESPP Purchase Rights

    The fair values of the ESPP purchase rights granted for the nine months ended February 28, 2021 and February 29, 2020 were estimated using the following assumptions:

 

   Nine Months Ended
   February 28,  February 29,
   2021  2020
       
Expected term (in years)   0.5-2.0    0.5-2.0 
Volatility   0.74-0.82    0.62-0.71 
Expected dividend  $0.00   $0.00 
Risk-free interest rate   0.10%-0.14%   1.56%-1.81%
Weighted average grant date fair value  $0.44   $0.80 
Stock option and RSU transactions

    The following tables summarize the Company’s stock option and RSU transactions during three and nine months ended February 28, 2021 (in thousands):

 

   Available
   Shares
Balance, May 31, 2020   1,650 
      
  Options granted   (200)
  RSUs granted   (196)
  Options cancelled   188 
  RSUs cancelled   2 
  Options expired   (125)
      
Balance, August 31, 2020   1,319 
      
  Options granted   (73)
  RSUs granted   (57)
  Options cancelled   185 
  Options expired   (162)
      
Balance, November 30, 2020   1,212 
      
  RSUs granted   (42)
  Shares withheld for taxes and not issued   4 
  Options cancelled   21 
      
Balance, February 28, 2021   1,195 

 

Stock option transactions

    The following table summarizes the stock option transactions during the three and nine months ended February 28, 2021 (in thousands, except per share data):

 

    Outstanding Options 
         Weighted      
    Number    Average    Aggregate 
    of    Exercise    Intrinsic 
    Shares    Price    Value 
Balances, May 31, 2020   3,153   $2.17   $102 
                
Options granted   200   $1.86      
Options cancelled   (188)  $2.18      
Options exercised   (148)  $1.30      
                
Balances, August 31, 2020   3,017   $2.19   $148 
                
Options granted   73   $1.44      
Options cancelled   (185)  $2.42      
Options exercised   (19)  $1.67      
                
Balances, November 30, 2020   2,886   $2.16   $56 
                
Options cancelled   (21)  $1.86      
Options exercised   (61)  $2.07      
                
Balances, February 28, 2021   2,804   $2.16   $1,994 
                
Options fully vested and expected to vest at February 28, 2021   2,769   $2.17   $1,967 

  

Options outstanding

    The options outstanding and exercisable at February 28, 2021 were in the following exercise price ranges (in thousands, except per share data):

 

   Options Outstanding  Options Exercisable
   at February 28, 2021  at February 28, 2021

Range of Exercise

Prices

  Number Outstanding Shares  Weighted Average Remaining Contractual Life (Years)  Weighted Average Exercise Price  Number Exercisable Shares  Weighted Average Remaining Contractual Life (Years)  Weighted Average Exercise Price  Aggregate Intrinsic Value
 $    1.22-$1.34    133    6.30   $1.27    36    6.36   $1.28      
 $    1.64-$1.86    1,047    5.04   $1.70    589    4.50   $1.69      
 $    2.03-$2.46    1,017    3.25   $2.21    781    2.86   $2.19      
 $    2.63-$2.81    405    0.66   $2.71    404    0.65   $2.71      
 $    3.46-$3.93    202    3.41   $3.86    184    3.41   $3.85      
 $    1.22-$3.93    2,804    3.70   $2.16    1,994    3.01   $2.28   $1,224